Ocular Therapeutix Inc Stock Price. Everything You Need To Know About The Ocular Therapeutix Inc Stock! Ocular Therapeutix Inc Stock Price. Everything You Need To Know About The Ocular Therapeutix Inc Stock!


Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. The company is headquartered in Bedford, Massachusetts and currently employs 274 full-time employees. The company went IPO on 2014-07-25. Its first commercial drug product, DEXTENZA, is developed for the treatment of ocular inflammation and pain ophthalmic surgery and ocular itching associated with allergic conjunctivitis. Its earlier stage development assets include: axitinib intravitreal implant (OTX-TKI), is under Phase I clinical trials for the treatment of wet age-related macular degeneration (AMD) and diabetic retinopathy; travoprost intracameral implant (OTX-TIC), is under Phase II clinical trial for the treatment of primary open-angle glaucoma or ocular hypertension; and dexamethasone intracanalicular insert (OTX-DED), for the short-term treatment of the signs and symptoms of dry eye disease; and cyclosporine intracanalicular insert (OTX-CSI), for the chronic treatment of dry eye disease, both of which have completed Phase II clinical trials.



Ocular Therapeutix Inc Stock Price. Everything You Need To Know About The Ocular Therapeutix Inc Stock! performance

  • Employees 274
  • Company HQ Bedford
  • Website https://www.ocutx.com/
  • OCUL Asset Type Common Stock
  • OCUL Market Capitalization 1B
  • Earnings Per Share -1.12
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth 0

Are you a retail investor from Malaysia, Thailand, Indonesia, or Vietnam looking to invest in the stock market? Look no further! Ocular Therapeutix is a promising stock that you should consider adding to your investment portfolio. Ocular Therapeutix is a biopharmaceutical company focused on developing innovative therapies for eye diseases. With their cutting-edge technology and a robust pipeline of potential treatments, Ocular Therapeutix shows great potential for growth in the coming years. As a retail investor, you can easily invest in Ocular Therapeutix stock through Zorion’s investment platform. Start making informed decisions and enhance your investment knowledge with Zorion’s investment insights and educational resources. Invest smartly with Zorion and don’t miss out on this lucrative opportunity to invest in Ocular Therapeutix.


Want To Buy Ocular Therapeutix Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: